Literature DB >> 8591878

Hypertensive urgencies and emergencies. Prevalence and clinical presentation.

B Zampaglione1, C Pascale, M Marchisio, P Cavallo-Perin.   

Abstract

The prevalence and clinical picture of hypertensive urgencies and emergencies in an emergency department are poorly known. The aim of the present study was to evaluate the prevalence of hypertensive crises (urgencies and emergencies) in an emergency department during 12 months of observation and the frequency of end-organ damage with related clinical pictures during the first 24 hours after presentation. Hypertensive crises (76% urgencies, 24% emergencies) represented more than one fourth of all medical urgencies-emergencies. The most frequent signs of presentation were headache (22%), epistaxis (17%), faintness, and psychomotor agitation (10%) in hypertensive urgencies and chest pain (27%), dyspnea (22%), and neurological deficit (21%) in hypertensive emergencies. Types of end-organ damage associated with hypertensive emergencies included cerebral infarction (24%), acute pulmonary edema (23%), and hypertensive encephalopathy (16%) as well as cerebral hemorrhage, which accounted for only 4.5%. Age (67 +/- 16 versus 60 +/- 14 years [mean +/- SD], P < .001) and diastolic blood pressure (130 +/- 15 versus 126 +/- 10 mm Hg, P < .002) were higher in hypertensive emergencies than urgencies. Hypertension that was unknown at presentation was present in 8% of hypertensive emergencies and 28% of hypertensive urgencies. In conclusion hypertensive urgencies and emergencies are common events in the emergency department and differ in their clinical patterns of presentation. Cerebral infarction and acute pulmonary edema are the most frequent types of end-organ damage in hypertensive emergencies.

Entities:  

Mesh:

Year:  1996        PMID: 8591878     DOI: 10.1161/01.hyp.27.1.144

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  94 in total

1.  Hypertensive emergencies in children.

Authors:  Pankaj Hari; Aditi Sinha
Journal:  Indian J Pediatr       Date:  2011-01-27       Impact factor: 1.967

2.  Hypertensive Crises.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

3.  Clinical and radiological features of brainstem variant of hypertensive encephalopathy.

Authors:  Ioannis Karakis; James A Macdonald; Maria Stefanidou; Carlos S Kase
Journal:  J Vasc Interv Neurol       Date:  2009-04

Review 4.  Control of blood pressure in hypertensive neurological emergencies.

Authors:  Lisa Manning; Thompson G Robinson; Craig S Anderson
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

5.  Clinical characteristics of Black patients with hypertensive urgency.

Authors:  Robert Munashe Maweni; Nicholas Sunderland; Zahra Rahim; Emmanuella Odih; Jins Kallampallil; Thomas Saunders; Srikanth Akunuri
Journal:  Ir J Med Sci       Date:  2018-03-14       Impact factor: 1.568

6.  Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts.

Authors:  Kyuho Jeong; Hayeong Kwon; Chanhee Min; Yunbae Pak
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

Review 7.  Is epistaxis associated with arterial hypertension? A systematic review of the literature.

Authors:  D Kikidis; K Tsioufis; V Papanikolaou; K Zerva; A Hantzakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-29       Impact factor: 2.503

Review 8.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

9.  Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review.

Authors:  W Frank Peacock; Jorge E Angeles; Karina M Soto; Philip D Lumb; Joseph Varon
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

10.  Hypertensive crisis-induced electrocardiographic changes: a case series.

Authors:  Khalid Abou Farha; André van Vliet; Sjoerd van Marle; Patrick Vrijlandt; Daan Westenbrink
Journal:  J Med Case Rep       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.